| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 16,363 | 21,621 | 18,682 | 12,313 | | Cost of Revenue |
-
|
-
|
-
| 19,606 | | | Gross Profit | 16,363 | 21,621 | 18,682 | (7,293) | | | Operating Expenses | | Research Development | (592) | 592 |
-
|
-
| | Selling General and Administrative | 15,862 | 18,158 | 16,905 | (15,953) | | Non Recurring |
-
| 2 | (2) |
-
| | Others |
-
|
-
|
-
| 15,207 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,092 | 2,868 | 1,779 | (6,546) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 1,092 | 2,868 | 1,779 | (6,546) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,092 | 2,868 | 1,779 | (6,546) | | Income Tax Expense | 123 | 753 | 344 | (2,596) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 969 | 2,115 | 1,435 | (3,950) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 969 | 2,115 | 1,435 | (3,950) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $969 | $2,115 | $1,435 | ($3,950) |
|
0.46% Nasdaq 
Income Statement
